Air Liquide Enters Exclusive Negotiations with Montagu Private Equity to Sell Aqua Lung
05 October 2016 - 2:35AM
Business Wire
Regulatory News:
Air Liquide (Paris:AI) announced today that it has entered into
exclusive negotiations with Montagu Private Equity, a leading
European private equity firm, for the potential sale of Aqua Lung,
a key player in personal aquatic equipment for recreational and
professional use. Air Liquide is focused on its Gas & Services
activities following the Group’s acquisition of Airgas, as well as
on the implementation of its company program NEOS for the 2016-2020
period.
If completed, the acquisition by Montagu Private Equity will
support Aqua Lung’s next phase of growth and its transformation as
a major consumer products player.
The transaction would be subject to the final and definitive
agreement between the parties and customary conditions and
provisions.
About Aqua LungPresent in
around 90 countries with approximately 1,000 employees, Air Liquide
subsidiary Aqua Lung is a key player in personal aquatic equipment
for recreational and professional use. Founded in 1946, Aqua Lung
is a historical expert in SCUBA diving and has expanded its
offering to complementary areas such as swimming, aqua fitness and
free diving. In 2015, Aqua Lung generated approximately €200
million in revenue.
About Montagu Private
EquityMontagu Private Equity is one of Europe’s leading
private equity firms. Founded in 1968, Montagu can look back on
more than 45 years’ experience in investing in more than 400
transactions. Montagu has a strong track record of supporting
portfolio companies, dedicating significant resources to management
teams as well as providing additional capital expenditure to fund
further growth. Montagu also has considerable expertise helping
businesses to accelerate their growth in their home markets as well
as to internationalise and expand their customer base. The firm has
assets under management of just over €5 billion.
_______________________________________________
The world leader in gases, technologies and services for
Industry and Health, Air Liquide is present in 80 countries with
approximately 68,000 employees and serves more than 3 million
customers and patients*. Oxygen, nitrogen and hydrogen are
essential small molecules for life, matter and energy. They embody
Air Liquide’s scientific territory and have been at the core of the
company’s activities since its creation in 1902.
Air Liquide’s ambition is to lead its industry, deliver
long-term performance and contribute to sustainability. The
company’s customer-centric transformation strategy aims at
profitable growth over the long term. It relies on operational
excellence, selective investments, open innovation and a network
organization implemented by the Group worldwide. Through the
commitment and inventiveness of its people, Air Liquide leverages
energy and environment transition, changes in healthcare and
digitization, and delivers greater value to all its
stakeholders.
Air Liquide’s revenues amounted to €16.4 billion in 2015, and
its solutions that protect life and the environment represented
more than 40% of sales. On 23 May 2016, Air Liquide completed its
acquisition of Airgas, which had revenues amounting to $5.3 billion
(around €4.8 billion) for the fiscal year ending 31 March 2016.Air
Liquide is listed on the Paris Euronext stock exchange (compartment
A) and belongs to the CAC 40 and Dow Jones Euro Stoxx 50
indexes.
* Following the acquisition of Airgas on 23 May 2016
www.airliquide.comFollow us on Twitter
@airliquidegroup
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161004006189/en/
Air LiquideCorporate CommunicationsCaroline
Philips, +33 (0)1 40 62 50 84Aurélie Wayser-Langevin, +33 (0)1 40
62 56 19Caroline Brugier, +33 (0)1 40 62 50 59orInvestor
RelationsParis+33 (0)1 40 62 50 87Radnor+1 610 263 8277
C3 AI (NYSE:AI)
Historical Stock Chart
From Jun 2024 to Jul 2024
C3 AI (NYSE:AI)
Historical Stock Chart
From Jul 2023 to Jul 2024